Menest (Estrogens) Drug Information: Overdosage and Contraindications

Pill Identifier Search

May 27, 2012

Menest

Osteoporosis »

Osteoporosis facts

Osteoporosis is a condition of increased susceptibility to fracture due to fragile bone.
Osteoporosis weakens bone and increases risk of bone fracture.
Bone mass (bone density) decreases after 35 years of age and decreases more rapidly in women after menopause.
Key risk factors for osteoporosis include genetics, lack of exercise, lack of calcium and vitamin D, personal history of fracture as an adult, cigarette smoking, excessive alcohol consumption, history of rheumatoid arthritis, low body weight, and family history of osteoporosis.
Patients with osteoporosis have no symptoms until bone fractures occur.
The diagnosis of osteoporosis can be suggested by X-rays and confirmed by tests to measure bone density.
Treatments for osteoporosis, in addition to prescription osteoporosis medications, include stopping use of alcohol and cigarettes, and assur...

Read the Osteoporosis article »

« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
Next »

Menest User Reviews >>

Menest

Take the Menopause Quiz

Menopause and Perimenopause Slideshow

Osteoporosis Slideshow Pictures

font size

OVERDOSE

Serious ill effects have not been reported following acute ingestion of large doses of estrogen-containing drug products by young children. Overdosage of estrogen may cause nausea and vomiting, and withdrawal bleeding may occur in females.

CONTRAINDICATIONS

Menest (estrogens) should not be used in women with any of the following conditions:

Undiagnosed abnormal genital bleeding.
Known,suspected, or history of cancer of the breast except in appropriately selected patients being treated for metastatic disease.
Known or suspected estrogen-dependent neoplasia.
Active deep vein thrombosis, pulmonary embolism or a history of these conditions.
Active or recent (e.g., within the past year) arterial thromboem-bolic disease (e.g.,stroke,myocardial infarction).
Liver dsyfunction or disease.
Menest (estrogens) should not be used in patients with known hypersensitivity to its ingredients.
Known or suspected pregnancy. There is no indication for Menest (estrogens) in pregnancy.There appears to be little or no increased risk of birth defects in children born to women who have used estrogens and progestins from oral contraceptives inadvertently during early pregnancy.(See PRECAUTIONS.)